Matt Maxwell

Clinical Research Holdings LLC provides commercial physical and biological research services. The firm specializes in Phase I/IIa Clinical Pharmacology, Outpatient Studies, In-Hospital Trials, Vaccines, Complex Clinical Trials, Special populations, Phase II, Phase III and Phase IV. The company was founded in 1998 and is headquartered in DeLand, FL.

Bridge Laboratories is a preclinical contract research organization (CRO) that provides US-level regulatory-compliant drug development services globally. Bridge is known for its extensive work in toxicology, including vaccines, and safety pharmacology. The company's AAALAC-accredited facility in China was among the first labs to perform GLP studies for clients worldwide. Bridge Laboratories gives drug development clients-biotech/pharmaceutical firms, government agencies and virtual companies with strong outsourcing needs-a CRO choice that can dramatically improve the speed and cost-effectiveness of their drug development research programs.

Frontage Laboratories, Inc. operates as a contract research organization which provides integrated, science-driven, product development services. It offers drug metabolism and pharmacokinetics, safety and toxicology, bioanalytical, chemistry, manufacturing, and control, clinical, biometrics, and agrochemical services. The company was founded by Song Li and Jie Du in 2001 and is headquartered in Exton, PA.

Avanza Laboratories LLC provides pharmaceutical and agrochemical support. The company is headquartered in Gaithersburg, MD.

AMPLIFY Clinical, Inc. operates as a clinical research site. It owns Meridian Research, Insearch Site Network and NeuroStudies. The company is headquartered in Winter Park, FL.

hyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The company is based in Columbus, GA. Each member operates as an independent company but integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices. It is an industry leader, providing phase i-iv clinical trial services with more than 100 active research sites on two continents and five countries. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. The company offers a vast network of leading clinical research sites committed to the highest standard of excellence in enrollment, data integrity, and timelines with the ability to conduct research across the majority of therapeutic areas. The company was founded in 2019, and the CEO is Karri Venn.

Access Clinical Partners LLC develops and operates regionally leading networks of outpatient healthcare facilities. The firm operates urgent care centers in the New York, Portland, OR, metropolitan areas and San Francisco Bay Area. The company is headquartered in Seattle, WA.